Universe Pharmaceuticals (UPC) Debt to Equity: 2020-2024
- Universe Pharmaceuticals' Debt to Equity fell 10.37% to $0.18 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.58, marking a year-over-year increase of 13.87%. This contributed to the annual value of $0.18 for FY2024, which is 10.37% down from last year.
- As of Q3 2024, Universe Pharmaceuticals' Debt to Equity stood at $0.18, which was down 32.25% from $0.26 recorded in Q1 2024.
- Universe Pharmaceuticals' Debt to Equity's 5-year high stood at $45,979 during Q3 2020, with a 5-year trough of $0.00 in Q1 2022.
- Moreover, its 3-year median value for Debt to Equity was $0.15 (2023), whereas its average is $0.14.
- Per our database at Business Quant, Universe Pharmaceuticals' Debt to Equity tumbled by 100.00% in 2021 and then soared by 96,748.37% in 2023.
- Over the past 5 years, Universe Pharmaceuticals' Debt to Equity (Quarterly) stood at $45,979 in 2020, then tumbled by 100.00% to $0.00 in 2021, then spiked by 22,689.02% to $0.10 in 2022, then skyrocketed by 104.93% to $0.20 in 2023, then declined by 10.37% to $0.18 in 2024.
- Its Debt to Equity stands at $0.18 for Q3 2024, versus $0.26 for Q1 2024 and $0.20 for Q3 2023.
